Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DL-Dapoxetine is a racemic mixture of the serotonin (5-HT) reuptake inhibitors (R)-dapoxetine and (S)-dapoxetine.1 (S)-Dapoxetine is more potent than (R)-dapoxetine in a serotonin reuptake assay using isolated rat cerebral cortex membranes (IC50s = 10 and 35 nM, respectively).2 (S)-Dapoxetine also inhibits the reuptake of norepinephrine and dopamine in cells expressing the human transporters (IC50s = 202 and 1,720 nM, respectively).3 Formulations containing (S)-dapoxetine have been used in the treatment of premature ejaculation.
WARNING This product is not for human or veterinary use.
1. Highly efficient, enantioselective syntheses of (S)-
2. 1-
3. Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation. J. Urol. 173(4), 239 (2005).